Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 3/20 | 0.47 |
| ▸ | AURKA | O14965 | 2/20 | 0.47 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.47 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.47 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.47 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | BLM | P54132 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28498261 | 0.96 | CDC25B (0.45) | CDC25BAURKAAURKBCYP1A1CYP1A2 | |
| SCHEMBL11664840 | 0.85 | — | — | |
| SCHEMBL19019862 | 0.82 | AURKA (0.36) | CDC25BAURKAAURKBCYP1A1CYP1A2 | |
| SCHEMBL1697785 | 0.77 | AURKA (0.38) | CDC25BAURKAAURKBCYP1A1CYP1A2 | |
| SCHEMBL16994960 | 0.77 | AURKA (0.38) | CDC25BAURKAAURKBCYP1A1CYP1A2 | |
| SCHEMBL2687051 | 0.77 | AURKA (0.38) | CDC25BAURKAAURKBCYP1A1CYP1A2 | |
| SCHEMBL187343 | 0.77 | MEN1 (0.48) | CDC25BAURKAAURKBCYP1A1CYP1A2 | |
| SCHEMBL899101 | 0.73 | AURKA (0.35) | CDC25BAURKAAURKBCYP1A1CYP1A2 | |
| SCHEMBL4443898 | 0.72 | CDC25B (0.39) | CDC25BAURKAAURKBCYP1A1CYP1A2 | |
| SCHEMBL5536618 | 0.71 | AURKA (0.33) | CDC25BAURKAAURKBCYP1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024262811-A1 | COMPOSITION FOR ELECTRODEPOSITION COATING OF IMIDE-BASED POLYMER FOR CONTROLLING FILM THICKNESS AND SUPPRESSING BUBBLE FORMATION, AND ELECTRODEPOSITION COATING METHOD USING SAME | 한국전기연구원 | 2024-12-26 | — | — | WO | claimed |
| US-20240344108-A1 | GALACTOSE RAPID QUANTITATIVE DETECTION SYSTEM AND USE THEREOF | Avalon HepaPOC Limited (HK) | 2024-10-17 | — | — | US | claimed |
| CN-117292952-B | Application of benzoquinone micromolecules as additive in preparation of electrolyte | 中山大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118440318-A | Anthraquinone-imino polymer and its synthesis and application | 武汉大学 | 2024-08-06 | — | — | CN | claimed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| WO-2024039075-A1 | ELECTRO-DEPOSITION COATING COMPOSITION INCLUDING REDOX SUBSTANCE, METHOD FOR MANUFACTURING SAME, AND ELECTRO-DEPOSITION COATING METHOD USING SAME | 한국전기연구원 | 2024-02-22 | — | — | WO | claimed |
| CN-117292952-A | Application of benzoquinone micromolecules as additive in preparation of electrolyte | 中山大学 | 2023-12-26 | — | — | CN | claimed |
| CN-116375736-A | Naphthol dioxazine imide compound and preparation method thereof | 大连理工大学 | 2023-07-04 | — | — | CN | claimed |
| CN-114984244-A | Hyperbranched polylysine-containing hydrogel carrier material and preparation method thereof | 浙江大学 | 2022-09-02 | — | — | CN | claimed |
| US-20210010050-A1 | ONE POT ELECTRO-CROSS-LINKING OF A PROTEIN FOR THE DEVELOPMENT OF A PROTEIN-BASED BIOSENSOR | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2021-01-14 | — | — | US | claimed |
| EP-1663120-A1 | USE OF BENZOQUINONES IN SUBSTANCES FOR THE OXIDATIVE TREATMENT OF HAIR AND METHOD AND SUBSTANCES FOR PERMANENT HAIR RESHAPING | Wella Aktiengesellschaft (DE) | 2006-06-07 | — | — | EP | claimed |
| EP-1257812-A4 | CAPILLARY ELECTROPHORESIS PROBES AND METHOD | ELECTRIC POWER RES INST (US) | 2006-06-07 | — | — | EP | claimed |
| WO-2005000259-A1 | USE OF BENZOQUINONES IN SUBSTANCES FOR THE OXIDATIVE TREATMENT OF HAIR AND METHOD AND SUBSTANCES FOR PERMANENT HAIR RESHAPING | WELLA AKTIENGESELLSCHAFT (DE) | 2005-01-06 | — | — | WO | claimed |
| US-6828347-B2 | Reacting a hydroxyquinone anion with a first quinone possessing a first directing group at a C-2 of the first quinone and a second directing group at a C-3 of the first quinone and obtaining a biquinone | ILLINOIS INSTITUTE OF TECHNOLOGY | 2004-12-07 | — | — | US | claimed |
| US-20040087663-A1 | Anti-viral multi-quinone compounds and regiospecific synthesis thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-05-06 | — | — | US | claimed |
| EP-1257812-A1 | CAPILLARY ELECTROPHORESIS PROBES AND METHOD | THE ELECTRIC POWER RESEARCH INSTITUTE (US) | 2002-11-20 | — | — | EP | claimed |
| US-20020092768-A1 | Capillary electrophoresis probes and method | ELECTRIC POWER RESEARCH INSTITUTE, INC. | 2002-07-18 | — | — | US | claimed |
| WO-2001040785-A1 | CAPILLARY ELECTROPHORESIS PROBES AND METHOD | ELECTRIC POWER RESEARCH INSTITUTE (US) | 2001-06-07 | — | — | WO | claimed |
| US-5237103-A | Oxidation of an olefin in the presence of a palladium catalyst and a water and cyclic ether solvent mixture | KEMITSU KOSAN COMPANY LIMITED (JP) | 1993-08-17 | — | — | US | claimed |
| US-4460554-A | Method of removing H2 S from a gas stream utilizing boron-vanadium, quinone solution and iron scavaging composition | PURTEC SYSTEMS, INC. (US) | 1984-07-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087663-A1 | Anti-viral multi-quinone compounds and regiospecific synthesis thereof | NQO1, QTRT1, NQO2 | CDC25B 726/4885AURKA 2104/4885AURKB 2358/4885 |
| US-20210010050-A1 | ONE POT ELECTRO-CROSS-LINKING OF A PROTEIN FOR THE DEVELOPMENT OF A PROTEIN-BASED BIOSENSOR | BMP2, FABP4, BMP4 | CDC25B 1159/4885AURKA 4662/4885AURKB 4672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.